Phase I study of epigenetic priming using decitabine with induction chemotherapy in patients with acute myelogenous leukemia (AML).
Phase of Trial: Phase I
Latest Information Update: 29 Jun 2011
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 09 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Oct 2007 New trial record.